Representative Richard W. Allen of Georgia’s 12th Congressional District reported a single-day portfolio adjustment on July 14, 2026, disposing of Abbott Laboratories common stock and purchasing shares in Advanced Micro Devices and Broadcom through his investment vehicle LIVTR.
The transactions were disclosed in compliance with the STOCK Act, which requires federal officials to report significant changes in financial holdings. Abbott Laboratories stock was sold for a value between $15,001 and $50,000, while purchases of Advanced Micro Devices and Broadcom each totaled between $1,001 and $15,000.
At the time of the trades, Abbott Laboratories was trading at $114.98, with a market capitalization of $198.94 billion. The company’s shares have declined 8.4% year-to-date. Abbott has maintained a 56-year streak of dividend payments, currently yielding 2.24%.
Allen’s purchases added exposure to two technology companies—Advanced Micro Devices and Broadcom—on the same day as the Abbott sale. The trades were reported on August 19, 2026.
